Treatment Horizons

Treatment Horizons

Protecting the Pipeline

LifeGuide HIV drug development faces challenges by Jeannie Wraight and Mariel Selbovitz, MPH Triple and now quad drugs like Gilead’s Atripla and their new compound known...

Status Update

LifeGuide Based in San Diego, a prevention model aims to reach everyone Everybody should be tested for HIV. That message is the basis for Lead...

Speed Test

An antigen and antibody combo assay zeroes in on acute infection Treatment Horizons by Chael Needle The diagnosis of acute HIV infection, when the virus is...

TB Announced

A not-for-profit biotech helps energize the future of TB vaccine R&D by Chael Needle According to the World Health Organization, tuberculosis is the most common illness...

Skin Cancers Revisited

Sun Blocked A new study examines non-melanoma skin cancers & HIV by Chael Needle In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...

Janssen Announces FDA Approval of SYMTUZA

The Janssen Pharmaceutical Companies of Johnson & Johnson announced on July 18, 2018 that the U.S. FDA has approved the use of SYMTUZA, the...

Cuts to Healthcare

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...

Expanded Portfolio

A new study reports on the drug-drug interaction between pitavastatin and a common PI combo by Chael Needle Last year, A&U reported on a study that...

TANGO Study Starts

In February 2018, ViiV Healthcare announced the start of a forty-eight-week phase III study designed to determine whether adults with HIV-1 who have achieved...

Use of HIV Preexposure Prophylaxis May Increase Use of Primary Care

A new study reveals that patients who use PrEP (Pre-exposure Prophylaxis ), a combination of the antiretroviral medications emtricitabine and tenofovir called Truvada, to...

LATEST POSTS

Revisit the Past—Just Don’t Wallow in It

Revisit the Past Just Don't Wallow in It by Hank Trout As I sat in the sun in my wheelchair earlier, plotting what I was going to...

5B, or Not to 5B